Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers

Summary

1. To investigate the safety and tolerability of Xerecept during and following a 24-hour intravenous administration to healthy Japanese to healthy Japanese and Caucasian subjects 2. To compare the PK profile of hCRF during and following a 24-hour intravenous Xerecept administration between healthy Japanese and Caucasian subjects

Timeline

Start

2008-12

Primary completion

2009-03

Completion

2009-04

Drugs

Indications

No indication recorded.